Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07278050Recruiting
Randomised, single-blind trial in shoulder pain and Shoulder disorder (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Opioid consumption (fentanyl) at 24 hours. Started Jan 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07278050.